Skip to main content
. Author manuscript; available in PMC: 2014 Feb 23.
Published in final edited form as: Reg Anesth Pain Med. 2013 Jul-Aug;38(4):274–281. doi: 10.1097/AAP.0b013e31828d0173

TABLE 2.

Incidence of Major In-hospital Complications, Mortality, and Resource Utilization by Group of Anesthesia

Complications
Neuraxial
Neuraxial/General
General
P
n % n % n %
Deep venous thrombosis 9 0.4 17 0.4 143 0.6 0.1327
Pulmonary embolism 15 0.5 20 0.4 144 0.6 0.1018
Cerebrovascular event 4 0.1 4 0.1 23 0.1 0.9383
Pulmonary complications 49 1.8 79 1.9 475 2.2 0.2622
Cardiac (non–myocardial infarction) 277 9.0 401 9.3 2103 9.2 0.9
Pneumonia 44 1.3 54 1.1 343 1.6 0.0605
All infections 125 3.8 192 4.2 1022 4.6 0.1166
Acute renal failure 82 2.8 125 2.7 701 3.2 0.1172
Gastrointestinal complication 29 0.9 43 0.9 298 1.3 0.0657
Acute myocardial infarction 11 0.4 10 0.2 54 0.2 0.258
Mortality (30-d) 3 0.1 9 0.2 48 0.2 0.2879
Blood transfusion 438 12.7 592 12.4 3230 13.8 0.0273*
Mechanical ventilation 119 2.8 139 2.8 945 4.4 <0.0001*
Critical care services admission 97 3.1 190 4.8 1647 6.9 <0.0001*

(MI = myocardial infarction).

The P value indicates testing of the null hypothesis (= no difference across all three groups: neuraxial [N], neuraxial/general [NG], and general [G]): χ2 test (for categorical outcomes).

*

Significant P values from post hoc comparisons: for outcome of blood transfusion: P = 0.0173(G vs NG); for outcome of mechanical ventilation: P < 0.0001 (G vs NG) and P < 0.001 (G vs N); for critical care service admission: P < 0.0001(G vs NG), P = 0.0015 (N vs NG), and P < 0.001 (G vs N).

HHS Vulnerability Disclosure